Literature DB >> 7784175

A trigonal form of the idarubicin:d(CGATCG) complex; crystal and molecular structure at 2.0 A resolution.

A Dautant1, B Langlois d'Estaintot, B Gallois, T Brown, W N Hunter.   

Abstract

The X-ray crystal structure of the complex between the anthracycline idarubicin and d(CGATCG) has been solved by molecular replacement and refined to a resolution of 2.0 A. The final R-factor is 0.19 for 3768 reflections with Fo > or = 2 sigma (Fo). The complex crystallizes in the trigonal space group P31 with unit cell parameters a = b = 52.996(4), c = 33.065(2) A, alpha = beta = 90 degree, gamma = 120 degree. The asymmetric unit consists of two duplexes, each one being complexed with two idarubicin drugs intercalated at the CpG steps, one spermine and 160 water molecules. The molecular packing underlines major groove-major groove interactions between neighbouring helices, and an unusually low value of the occupied fraction of the unit cell due to a large solvent channel of approximately 30 A diameter. This is the first trigonal crystal form of a DNA-anthracycline complex. The structure is compared with the previously reported structure of the same complex crystallizing in a tetragonal form. The geometry of both the double helices and the intercalation site are conserved as are the intramolecular interactions despite the different crystal forms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784175      PMCID: PMC306926          DOI: 10.1093/nar/23.10.1710

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  14 in total

1.  The molecular structure of a 4'-epiadriamycin complex with d(TGATCA) at 1.7A resolution: comparison with the structure of 4'-epiadriamycin d(TGTACA) and d(CGATCG) complexes.

Authors:  B Langlois d'Estaintot; B Gallois; T Brown; W N Hunter
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

2.  Crystallographic refinement of yeast aspartic acid transfer RNA.

Authors:  E Westhof; P Dumas; D Moras
Journal:  J Mol Biol       Date:  1985-07-05       Impact factor: 5.469

3.  Structure of a B-DNA dodecamer. III. Geometry of hydration.

Authors:  H R Drew; R E Dickerson
Journal:  J Mol Biol       Date:  1981-09-25       Impact factor: 5.469

4.  DNA-drug interactions. The crystal structure of d(CGATCG) complexed with daunomycin.

Authors:  M H Moore; W N Hunter; B L d'Estaintot; O Kennard
Journal:  J Mol Biol       Date:  1989-04-20       Impact factor: 5.469

5.  Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers.

Authors:  F Arcamone; L Bernardi; P Giardino; B Patelli; A Marco; A M Casazza; G Pratesi; P Reggiani
Journal:  Cancer Treat Rep       Date:  1976-07

6.  The structure of an idarubicin-d(TGATCA) complex at high resolution.

Authors:  B Gallois; B L d'Estaintot; T Brown; W N Hunter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1993-05-01

7.  Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG).

Authors:  Y G Gao; A H Wang
Journal:  Anticancer Drug Des       Date:  1991-07

8.  Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).

Authors:  G J Quigley; A H Wang; G Ughetto; G van der Marel; J H van Boom; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

9.  Anthracycline binding to DNA. High-resolution structure of d(TGTACA) complexed with 4'-epiadriamycin.

Authors:  G A Leonard; T Brown; W N Hunter
Journal:  Eur J Biochem       Date:  1992-02-15

10.  Anthracycline-DNA interactions at unfavourable base-pair triplet-binding sites: structures of d(CGGCCG)/daunomycin and d(TGGCCA)/adriamycin complexes.

Authors:  G A Leonard; T W Hambley; K McAuley-Hecht; T Brown; W N Hunter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1993-09-01
View more
  2 in total

1.  Quinoline alkaloids as intercalative topoisomerase inhibitors.

Authors:  Kendall G Byler; Chen Wang; William N Setzer
Journal:  J Mol Model       Date:  2009-05-08       Impact factor: 1.810

2.  Indirect readout in drug-DNA recognition: role of sequence-dependent DNA conformation.

Authors:  Marcos J Araúzo-Bravo; Akinori Sarai
Journal:  Nucleic Acids Res       Date:  2007-11-26       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.